Status:
COMPLETED
Mitomycin-c Application for PRK
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Myopia
Eligibility:
All Genders
Phase:
NA
Brief Summary
To evaluate the safety and efficacy of 5 seconds mitomycin-C (MMC) application during photorefractive keratectomy (PRK) for patients with low myopia.
Eligibility Criteria
Inclusion
- The inclusion criteria was ablation depth less than 65 µm,
- a stable refractive error for at least 1 year
- corrected distance visual acuity (CDVA) of 0.1 LogMAR or better.
Exclusion
- Patients with keratoconus suspect,
- excessive dry eyes,
- impaired wound healing processes,
- lenticular changes,
- corneal dystrophy,
- history of ocular surgery,
- anterior or posterior uveitis,
- glaucoma and retinal diseases were excluded.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01504282
Last Update
January 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Research Center
Tehran, Tehran Province, Iran, 16666